Box score
Allyx Therapeutics, Inc.
Reported $26.4M sold in a new Form D filed May 11, 2026 (New Haven, Connecticut).
- Biggest raise
- $26.4M filed May 11, 2026
- League
- Bio & Health Biotechnology
- Based in
- New Haven, Connecticut
- Season rank
- #99 of 1,121 in the Bio & Health League; #830 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-10-21 | Amendment | $27.9M | $30M | SEC |
| 2026-05-11 | New notice | $26.4M | $30M | SEC |
| 2026-03-03 | New notice | $3.3M | $4M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1865257.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Oxbridge Health, Inc. rookie | Bio & Health | $38.5M |
| 2 | Veradermics, Inc | Bio & Health | $30M |
| 3 | Cloverleaf Bio, Inc. rookie | Bio & Health | $14.8M |
| 4 | Quarry Heme, Inc rookie | Bio & Health | $13.5M |
| 5 | Convexity Scientific Inc. | Bio & Health | $10M |
| 6 | Oncosynergy, Inc. | Bio & Health | $6.6M |